Symbiotec Pharmalab Overview
- Year Founded
-
2002
- Status
-
Public
- Employees
-
1,915
- Stock Symbol
-
SYMBIOTEC
- Share Price
-
$17.53
- (As of Thursday Closing)
Symbiotec Pharmalab General Information
Description
Symbiotec Pharmalab Ltd is a research and development-driven, science-based pharmaceutical and biotechnology company with capabilities across three platforms: organic chemistry, biotechnology and complex injectables. The company is engaged in the business of manufacturing and selling of Active Pharmaceutical Ingredients (API) and Intermediates. In addition to manufacturing API products that it sells, the company offers its services as a contract development and manufacturing organisation (CDMO) for specialty pharmaceutical and nutraceutical companies. The company derives almost all of its revenue from the sale of API products, including corticosteroids and steroidal-hormones. Its product portfolio includes Cortico-Steroids, both Sterile & Non-Sterile, and Steroid Hormone APIs, etc.
Contact Information
Website
www.symbiotec.comCorporate Office
- 385/2, Pigdamber, Rau
- Mhow
- Indore, Madhya Pradesh 453331
- India
Corporate Office
- 385/2, Pigdamber, Rau
- Mhow
- Indore, Madhya Pradesh 453331
- India
Symbiotec Pharmalab Stock Performance
As of 12-Nov-2026, Symbiotec Pharmalab’s stock price is $17.53. Its current market cap is $1.13B with 64.3M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $17.53 | $16.38 | $9.82 - $17.66 | $1.13B | 64.3M | 2.01M | $0.21 |
Symbiotec Pharmalab Financials Summary
As of 30-Sep-2026, Symbiotec Pharmalab has a trailing 12-month revenue of $104M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 824,022 | |||
| Revenue | 104,460 | 98,360 | 88,881 | 86,518 |
| EBITDA | 27,835 | 26,252 | 24,375 | 21,385 |
| Net Income | 13,646 | 12,435 | 11,446 | 12,100 |
| Total Assets | 212,794 | 188,738 | 184,670 | 155,262 |
| Total Debt | 34,972 | 41,439 | 63,648 | 30,050 |
Symbiotec Pharmalab Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Symbiotec Pharmalab Comparisons
Industry
Financing
Details
Symbiotec Pharmalab Competitors (19)
One of Symbiotec Pharmalab’s 19 competitors is Dalton Pharma Services, a Corporate Backed or Acquired company based in Toronto, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dalton Pharma Services | Corporate Backed or Acquired | Toronto, Canada | ||||
| La Chandra Pharmalab Private | Corporation | Ahmedabad, India | ||||
| Rottendorf Pharma | Corporation | Ennigerloh, Germany | ||||
| Symed Labs | Formerly PE-Backed | Hyderabad, India | ||||
| Laborate Pharmaceuticals India | Corporation | Panipat, India |
Symbiotec Pharmalab Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Symbiotec Pharmalab Patents
Symbiotec Pharmalab Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10555592-B2 | Application for topical composition | Inactive | 31-Aug-2017 | ||
| US-20190059552-A1 | Application for topical composition | Active | 31-Aug-2017 |
Symbiotec Pharmalab Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Symbiotec Pharmalab FAQs
-
When was Symbiotec Pharmalab founded?
Symbiotec Pharmalab was founded in 2002.
-
Where is Symbiotec Pharmalab headquartered?
Symbiotec Pharmalab is headquartered in Indore, India.
-
What is the size of Symbiotec Pharmalab?
Symbiotec Pharmalab has 1,915 total employees.
-
What industry is Symbiotec Pharmalab in?
Symbiotec Pharmalab’s primary industry is Pharmaceuticals.
-
Is Symbiotec Pharmalab a private or public company?
Symbiotec Pharmalab is a Public company.
-
What is Symbiotec Pharmalab’s stock symbol?
The ticker symbol for Symbiotec Pharmalab is SYMBIOTEC.
-
What is the current stock price of Symbiotec Pharmalab?
As of 12-Nov-2026 the stock price of Symbiotec Pharmalab is $17.53.
-
What is the current market cap of Symbiotec Pharmalab?
The current market capitalization of Symbiotec Pharmalab is $1.13B.
-
What is Symbiotec Pharmalab’s current revenue?
The trailing twelve month revenue for Symbiotec Pharmalab is $104M.
-
Who are Symbiotec Pharmalab’s competitors?
Dalton Pharma Services, La Chandra Pharmalab Private, Rottendorf Pharma, Symed Labs, and Laborate Pharmaceuticals India are some of the 19 competitors of Symbiotec Pharmalab.
-
What is Symbiotec Pharmalab’s annual earnings per share (EPS)?
Symbiotec Pharmalab’s EPS for 12 months was $0.21.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
